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THE observations that urethane (ethyl carbamate) inhibited the growth of
transplantedtumou'rs(HaddowandSexton, 1946) and caused afallintheleucocyte
countin chronicmyeloidleukaniia(Paterson,ApThomas, Haddow andWatkinson,
1946) were made inEngland a few years after thediscovery that urethane induced
adenomas ofthelung in mice (Nettleship, Henshaw andMeyer, 1943) was made in
the United States. The earlier observations of Hawkins and Murphy (1925)
on the leucopenic action of urethane appear to have been overlooked.
Urethane is one of the earliest known chemical mutagens; its genetical effects
on the chromosomes of Oenothera and Campanula were described by Oehlkers
in 1943. Vogt (1948) has show-n that the mutation rate in the fly Drosophila
increased after injections of urethane into the abdominal cavity of adult males.
It has been reported that urethane inhibits mitosis in various tissues of different
organisms (Dustin, 1947; GA'uyer and Claus, 1947 ; Comman, 1950). The effects
of urethane in tissue cultures have been studied in detail by Bucher, (1947)
and Bastrup-Madsen (1949). Haddow and Sexton (1946) reported that urethane
inhibits thegrowth ofthe Walker carcinoma ; they found that 12intra-peritoneal
injections of 50 mg. urethane per rat reduced the mean weight of the tumours
to one-sixth of that of the corresponding controls.
Urethane and Cell Xetaboli8M.
The metabolism of urethane in animals has'been demonstrated by chemical
analysis (Boyland and Rhoden, 1949) and by tracer t'echnique (Skipper, Bennett,
Bryan, White, Newton and Simpson, 1951). Although in the concentrations
(M/10) required for anaesthesia, urethane inhibits many enzymes (e.g., choline
oxidase and succinoxidase), it has no pronounced action when present in concen-
trations (M/100) which produce lung adenomas or leucopenia (Boyland and
Wilhams-Ashman, 1951). A-n indication of specific enzyme inhibition with ure-
thane was described by McKinney (1950) who found that M/100 ethyl carbamate
inhibited the methylation of nicotinamide or glycocyamine by isolated tissues,
while methyl carbamate was much less active in this respect. The fact that ure-
thane inhibits trans-methylation' reactions suggests that it would inhibit the
biosynthesis of thymine, as the methyl group of the latter is introduced by a
trans-methylation reaction. (Elwyn and Sprinson, 1950). In order to test this
hypothesis, experiments were carried out to compare the effects of urethane
andthymine on thedividing cells ofthe Walker carcinoma. Ifit could be demon-
strated that the urethane-induced mitotic inj'ur'ies are affected by pre-treatment
with thymine, some light might be thrown on the mechanism of its action in the678 E. BOYLAND AND P. C. KOLLER
cell. In this respect an important observation has already been made by Cowan
(1949) who found that the administration of mixed pentose nucleotides reduced
the carcinogenic action of urethane.
EXPERIMENTAL PROCEDURE.
Adult albino rats ofboth sexes between the ages of 5 and 6 weeks wereimplan-
ted subcutaneously with grafts of Walker carcinoma 256. Intra-peritoneal
injections of urethane were commenced six days after implantation. In the
preliminary experiments, 1 to 8 doses of 1,000 or 500 mg./Kg. bodyweight were
given. When repeated doses were required, injections were g'lven twice daily
at 10 a.m. and 4 p.m.
Cytological analysis was carried out on small pieces of tumour tissue, fixed
in a mixture of 3 parts absolute alcohol and I part glacial acetic acid. Squash
preparations were made and stained with lacmoid and Feulgen's basic fuchsin.
For quantitative compai-ison the proportion of abnormal mitoses was determined
in specimens taken from rats killed at different times, varying between 24 and 96
hours after the last injection of urethane.
Reduction ofmitosis.
Thedaily administration ofurethane causedsystemic effects such assleepiness,
reduction offood intakeleading to loss ofweight, and to reducti-on in the number
of dividing cells in the tumour. Table I shows the frequency distribution of
mitosis and Table II gives the number of abnormal divisions, after various doses
of urethane. The repeated administration of this drug produces histological
changes which consist of the transformation of the cellular Walker carcinoma
into a fibrous or
" sarcomatous
" tissue complex. The histological alteration
has been notedby Haddow and Sexton (1946), describedby Green andLushbaugh
(1949) and its underlying causes analysed in detail by Koller and Casarini (1952).
The present investigation brought to light further evidence which shows that
fibrous
" differentiation
" is preceded by a severe reduction in the number of
dividing tumour cells.
The study ofthe various cytological effects inducedby urethane in the mitotic
cells of Walker carcinoma, has been carried out between 1947 and 1954 and the
data obtained are summarized in Table III. There isrelativelygood agreement
between the various experiments. The incidence of abnormal cells observed in
different tumours of the same experiments is sufficiently consistent to allow a
quantitative comparison of the data.
TABLEL-Proportion of Cell8in Mitosis in 9-day8-old Walker Carcinoma.
(Average number of ceRs examined 450-500)*
Cells in mitosis
(per cent of
Treatment. total counted).
nil 4- 8
5 x 500 mg./Kg. Urethanet 1-6
6 x 500mg./Kg. Urethanet 2-4
8 x 500 mg./Kg. Urethanet 1-2
Ten cell populations of a squash preparation wero analysed by using x 45 oil immersion
objective and x 10 compensating eyepiece (Cooke). Average number of cens per field was 35.
t Fixation of tumour sample was made 24 hours after the last injection with uretbane.EFFECTS OF URETHANE ON MITOSIS 679
TABLEII.-The Frequency of Abnormal MitO8i8 in the Walker Tumour.
(24 hours after the last dose ofUrethane.)
Abnormal mitosis
(per ceiit).
18 (50)*
37 (50)
39 (69)t
28 (37)
25 (55)
36 (50)t
Dose of urethaiie.
I x 1600 mg./Kg.
2 x 1000 11
3 x 1000 9 9
1 x 500 mg./Kg.
2 x 500 9 .
3 x 500 9 31
* Numbers in parenthesis refer to the number of cells exaiiiined.
t About half of the abnormal cells show severe cytoplasmic disturbances.
TABLE III.-Abnormal Alito8i-sfollowing tTrethane I'reatment.
Cells with
abnormal mitosis
(as per cent of
total examined).
34 (38)*
38 (34)
40 (47)
48 (40)
44 (48)
40 (45)
46 (48)
37 (84)
39 (36)
28 (58)
19 (62)
36 (72)
17 (75)
34 (5)6)
17(75)
Dose of
Urethane*
(mg.).
2 x 500
2 x 500
1 x500
2 x 500
2 x 500
1 X500
1 x500
I x 500
1 x 500
2 x 500
2 x 500
1-1 x 500
1 x500
I x500
2 x 500
Time in hours
after in.ection. i
24
24
24
48
48
48
48
48
56
72
72
72
72
72
96
Date of
Experiment.
2I -xi. 1947
16.vi. 1951
6.xi. 1953
1 1 .viii. 1950
6. x. 1952
22.xi. 1947
14.iv. 1948
7.xi. 1953
14.iv. 1948
12.viii. 1950
18 vi 1951
7. x. 1952
23. xi. 1947
15. iv. 1948
24 xi 194-i
Number in parenthesis refer to the number of cells examiiie(l.
t Per kg. body weight of rats.
Effect8 of urethane.
The increasing amount of chromosome injuries and other mitotic disturbances
which appear in tumour cells after repeated administrations of urethane makes
cytological analysis difficult. Many of the drastic abnormalities in dividing
cells are obviously cytoplasmic in origin and constitute a different class from that
of the radiomimetic effects. Owing to the difficulty in discriminating between
the various types of mitotic disturbances in tumours treated with more than 3
doses of urethane the quantitative studies have been restricted to tumours which
were treated with I or 2 doses ofurethane, (500-1000 mg./Kg.). These doses are
much below those necessary to cause a significant inhibition of growth, and the
frequency of abnormal cells in the tumour never exceeds 50 per cent of the total
number of dividing cells analysed. In this respect urethane is less e-fficient than
either HN2 or X-rays. By single treatment with HN2, it is possible to induce
chromosome damage in 90 per cent, and with X-rays in 80 per cent of the dividing
cells of the Walker carcinoma.
After the administration of urethane cvtolovical abnormalities are seen at all
stages of mitosis. Furthermore, it was found that cells in the interphase can680 E. BOYLAND AND P. C. KOLLER
also show morphological changes. The original intention was to analyse and
score only the post-metaphase stages of mitosis for chromosome injuries, because
in these stages (Fig. 1 and 2) the fragmented chromosomes and chromosome
bridges can be readily identified, (Devik, Elson, Koller and Lamerton, 1950 ;
Koller and Casar'im', 1952). In view of the fact that mitotic disturbances after
more than one dose ofurethane areusually severe and the stage of mitosis cannot
be identified (Fig. 3 and 4), the class of injured cells which are recorded very
likely contain many cells inpre-metaphase or metaphase stage.
In untreated Walker tumours the sole mitotic abnormality is stickiness of
chromosomes during anaphase, which is seen in 3 to 6 per cent of cells in necrotic
areas, and in 0-5 to I per cent in the healthy growing areas (Koller and Casar'im',
1952).
Cytological effect8 of urethane and thymine, combined.
Administration of thymine alone (50 mg./Kg. body weight) produced no
mitotic disturbances in the tumour cells examined 24, 48, and 72 hours after
dosing (Experiment 1, Table IV). When 2 or 3 doses of thymine are injected
into tumour bearing rats the only effect is a slight increase in the number of divi-
ding cells which clumped chromosomes at metaphase. In one series of experi-
ments thymine, which alone does not induce chromosome abnormalities, was
injected together with urethane (500 mg./Kg.). The results have show-n that
while the number of abnormal cells 24 hr. after the combined administration of
TABLIF, IV.-Effect of Treatment by Urethane and Thymine.
Abnorinal mitoses as per cent of total cells
Experi- Treatment at times counted at different times after last
ment (in hours). dose of urethane (in hours).
No. r
A
0. 6. 18. 24. 24. 48. 72. 96.
1 U+T U+T T 29 (56) 21 (80)
T T T 0 (50) 3 (64)
2 U+T U+T 37 (49) 23 (71) 14 (56)
u u 38 (34) 36 (72)
U+T U+T 25 (92) 18 (65) 11 (53)
3 T T 0 (50) 2 (50) 4 (52)
u u 34 (38) 44 (48) 19 (62)
u 40 (45) 43 (42) 17 (75)
4 T U+T T T 40 (50) 22 (37) 11 (93)
u u 48 (40) 28 (58) 17 (75)
T T T TU 30 (78) 21 (42)
5 T T TU 37 (43) 38 (73)
u 40 (47) 37 (84)
Numbers in brackets indicate numbers of cells counted.
U = Intraperitoneal injection of Urethane (500 mg.Kg. body weight).
Intraperitoneal injection ofThymine (50 m ./Kg. body weight).
EXPLANATION OF PLATE.
FIG. l.-Anaphase ofmitosis in a tumour ceRshowing onep6,ir offused chromosomefragments
and a broken chromosome bridge (24 hours after 1 x 500 mg./Kg. Urethane). x 1300.
FIG. 2.-Late anaphase at which several chromosome fragments are left behind the other
chromosomes (48 hours after 4 x 500 mg./Kg. Urethane). x 1300.
FIG. 3.-Mitosis of a tumour ceR in which many chromosomes have been broken. The stage
of mitosis cannot be recognised (24 hours after 6 x 500 mg./Kg. Urethane). X 1300.
FIG. 4.-Spindle abnorxnality and chromosome fragmentation in a dividing tumour cell
(24 hours after 8 x 500 mg./Kg. Urethane). x 1300.Vol. VIII, No. 4. BRITISH JOURlqAL OF CANCER.
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tthe drugs was not affected, the reduction in the incidence of abnormal cells was
significant in tumour samples taken 48 hr. after dosing the animals (Experiments
2 and 3, Table IV). The data suggested that the influence of thymine on the
urethane-induced injuries might be delayed. In other experiments therefore,
rats were injected repeatedly with thymine and the administration of thymine
commenced 6 hr. beforedosing them withurethane. Theexperiments have shown
that the incidence ofabnormal cells 24 hr. after the administrationofurethane was
not affected by the pre-treatment with thym'me (Experiment 4, Table IV).
When, however, pre-treatment commenced earher, i.e. 24 hr. before the rats were
injected with urethane, the incidence of abnormal mitosis was reduced in all the
tumour samples (Experiment 5, Table IV). The results seem to indicate that
thymine accelerates the recovery of cells from the effect of urethane.
In order to find out if this is the case the incidence of abnormaRy dividing
tumour cells given in Table IV have been divided into two groups for statistical
treatment. These groups contain the data obtained either less or more than 48
hr. after the administration of urethane. The statistical analysis (Table V)
shows that the reduction ofthe urethane-induced effects bythymine is significant
in both groups, which suggests that the reduction cannot. be due to recovery
alone. It is more likely that urethane interferes with the intracellular synthesis
of thymine and thus disturbs nucleic acid metabolism. The introduction of an
excess amount ofthymine by pre-treatment seems to maintain normal synthesis.
TABLEV.-Compari8on of the Effect8by Urethane, by Thymine and by their
Combination.
Substance.
Urethane Urethane Urethane Urethane
alone. + thymine. alone. + thymine.
Time of observation.
A
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r-
Less than 48 hours.
t
A
40 40
43 22
48 25
34 37
44 23
38 29
46 35
39 25
40 30
37 21
40 39
11 11
41-1 29-5
4- 6 6.9
11.1 23-4
%-
12-0
- -
More than 48 hours
A
-I r
17 11
28 18
17 11
19 14
36 21
34 16
L
Percentage of abnormal cells .
Number of observations
Mean value
S.D.
Coefficient of variation
Difference of means
Significance of difference:
t
Difference of coefficient of variation
Significance of difference:
t
6 6
25- 1 15- 1
8- 7 4- 1
34- 7 27- 2
k
10.0
3- 84
-0015
12-3%
2-60
-015
7-5%
1.89
0-08
0.59
0.55Treatment at times
(in hours).
A
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Experiments with urethane, diaminopurine, nitrogen mustard, uracil and
guano8ine.
Skipper and Schabel, (1952) found that the inhibition of growth of E. coli
by urethane can be reversedby 2: 6-diaminopurine. The latter agent is a purine
antagonist and is known to be a growth inhibitor of particular tumours (Elion
and Hitchings, 1950). Professor Haddow found that a combination of urethane
and diaminopurine inhibits the growth of the Walker carcinoma. The data in
Table VI show that when urethane (50 mg. per rat) or 2: 6-diaminopurine (10
mg. per rat) are administered daily to tumour bearing rats, the growth of these
particular carcinomata is reduced as compared with the control tumours.
TABLE VI.-The effect of Urethane and 2: 6-Diaminopurine on the
Growth of the Walker Carcinoma.
Weight of tumours g. Meanweight of
Treatment.* at 13 days. tumours (g.).
Contr'ol 60 51 50 39 37 32 29 23 5 36
Urethane, 8 x 50 mg. 51 36 28 26 23 22 20 19 11 8 24
2: 6-Diaminopurine, 8 x 10 mg. 35 30 29 26 24 23 19 17 15 13 23
Urethane, 8 x 50 g., plus 2 : 6-
Diaminopurine, 8 x 10 mg. 13 8 5 5 5 4 3 3 1 1 4
* Doses in mg. per rat; average weight 180 gm.
The cytological analysis of tumours treated with 2 : 6-diaminopurine alone
failed to disclose cells with mitotic abnormalities. Furthermore, when 2 : 6-
diaminopurine is combined with urethane the number of abnormally dividing
cells was found to be nearly the same as after urethane treatment alone (Table
VII). The additive effect of growth-inhibition by diaminopurine and urethane
is vervlikely a complex process which cannot be identifiedbycytologicalanalysis.
TABLEVII.-The Effect8of Combined Treatment on the Chromo8ome
Abnormalitie8in Walker Carcinoma.
Abnorinal mitoses per cent at different
times after treatment*
(in hours).
r- ---I f..
0.
T
DAP
DAP
T
Uc
G
24.
T
n A'P
6.
u
U+T
TT n AP I
18.
T
,nA,p
18. 24. 36.
46 (48)t
35 (49)
38 (66)
6 (100)
4 (50) 34 (50)
8 (50) 36 (50)
34 (43)
42 (56)
3 (52)
43 (73)
37 (43)
32 (55)
u -t-JuAr -uAr -ular .
HN2 24
HN2+T U
u
U+Uc Uc Uc .
Uc
G G G+U
G G+U
u
DAP = Intraperitoneal injection of 2: 6-Diaminopurine (50 mg./Kg. body weight).
HN2 = Intraperitoneal injection of 2: 2'-Dichlorodiethyl methylamine hydrochloride (0-5
mg./Kg. body weight).
Uc = Intraperitoneal injection of Uracil (50 mg./Kg. body weight).
G = Intraperitoneal injection of Guanosine (200 mg./Kg. body weight).
* Time interval is calculated from the last dose of urethane or HN2.
t The number in parenthesis indicate the total number of cells analysed.
48. 72.
39 (36) 34 (56)
25 (56) 16 (64)
40 (52) 36 (50)
0 (100) 0 (100)
74 (50) 74 (50)
70 (50) 60 (50)
58 (79) 38 (40)
44 (59) 43 (46)
2 (47) 0 (50)
30 (39)
29 (54)
31 (61)EFFECTS OF URETHANE ON MITOSIS 683
In other experiments, nitrogen mustard (HN2) with thymine was used in
order to detectpossiblesynergistic effects oftheseagents in the cells ofthe Walker
tumour (Table VII). It has been found that a single dose of HN2 (I mg./Kg.
bodyweight) inhibits the growth of this tumour (Boyland, Clegg, Koller, Rhoden
and Warwick, 1948). The cytological basis of growth-inhibition has been
investigated in detail by Koller and Casarini (1952). When thymine'was com-
bined with HN2, there was only slight reduction in the number of cells showing
mitotic abnormalities.
In similar experiments urethane was administered with uracil and guanosine
(Table VII). Whfle uracil did not reduce the incidence of mitotic abnormalities
produced by urethane, guanosine appeared to cause a slight increase in the
incidence of abnormal mitoses.
DISCUSSION
The experiments show clear differences between urethane and nitrogen
mustard, both of which may be considered as agents with radiomimetic effects.
They differ very much in destructive potency. Whereas a single dose ofnitrogen
mustard readily produces injuries in almost every dividing cell of the Walker
tumour, it was found that even repeated administration'of urethane could not
produce chromosomeinjuries in more than half ofthe dividing ceRsanalysed at a
p.articular time. Our experiments also show that the effect of urethane is con-
siderably reducedby treatment withthymine (though notbyguanosine oruracil),
while the effect of nitrogen mustard is not altered in the presence of thymine.
Thesefindings agree with (but do not prove) thehypothesis that urethane and
nitrogen mustard produce their radiomimetic effects by different mechanisms
(Boyland, 1952). There is some evidence to show that HN2 affects directly
chromosome synthesis (Butler and Smith, 1950). On the other hand, there are
indications that the effect of urethane on the cellular pentose nucleic acid (DNA)
synthesis is indirect. Thus, urethane by interfering with thymine synthegis
can cause a specific deficienc of th 'dine or deoxyribonucleic acid. A drug
working by such a mechanism might be expected to be' more effective when
metabolism and growth were rapid and prod-ticing a greater demand on nucleic
acid precursors. Di Paolo (1952) has demonstrated that increased oxygen
tension increased the genetical effect of urethane in Drosophila, and suggests that the increased metabohc rate due to oxygenation made the cells more suscep-
tible to urethane. If uretbane acts on the chromosomes by way of particular
cytoplasmic enzymes, then the finding of Oehlkers (1946) is of special interest.
He observed in the urethane-induced chromosonie injuries significant differences
between the reciprocal crosses of two Oenothera species, which could be due only
to differences in the cytoplasmic metabohsm.
SUMMARY.
(1) Urethane produces abnormahties, consisting ofchromosome fragmentation
and anaphase bridges in a proportion (never exceeding half) of the dividing cells
of the Walker rat carcinoma.
(2) Thefrequency of abnormal mitoses due to urethaneis reduced andrecovery accelerated by simultaneous administration ofthymine.684 E. BOYLAND AND P. C. KOLLER
(3) The frequencyof abnormal mitosis produced byurethane was not reduced
by administration of diaminopurine or uracil and was slightly increased by
guanosine.
(4) Thymine did not affect thefrequency of abnormal mitoses in the Walker
tumour produced bynitrogen mustard.
(5) It is suggested that urethane may interfere in the cell with thymine syn-
thesis by inhibitingtrans-methylation reactions.
We are indebted to Dr. G. H. Hitchings for a gift of 2: 6-diaminopurine, to
Professor A. Haddow for the datain Table VI and to Dr. R. A. M. Case for the
statistical analysis ofTable V. This investigation has been supported by grants
to the Royal Cancer Hospital and Chester Beatty Research Institute from the
BritishEmpire CancerCampaign, theJaneCoffmChildsMemorial FundforMedical
Research, theAnnaFullerFund, andtheNational Cancer Institute oftheNational
Institutes ofHealth, U. S. Public Health Service.
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